Related Experiment Video
Updated: Jun 18, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Visualized and pH-responsive hydrogel antibacterial coating for ventilator-associated pneumonia.
Baokang Zhu1, Hui Xin1, Musheng Yang1
1Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China; Intensive Care Unit, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen 518031, China.
A novel antimicrobial coating for endotracheal tubes (ETTs) visualizes bacterial infections and releases drugs to prevent ventilator-associated pneumonia (VAP). This coating demonstrated significant anti-biofilm and anti-bacterial properties in rat models.
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Medical Device Coatings
Background:
- Ventilator-associated pneumonia (VAP) is a serious healthcare-acquired infection linked to bacterial colonization on endotracheal tubes (ETTs).
- Existing ETTs provide a surface for bacterial biofilm formation, complicating infection control, especially in prolonged ventilation scenarios like those seen with COVID-19.
Purpose of the Study:
- To develop a pH-responsive antimicrobial coating for ETTs that can both indicate infection and deliver therapeutic agents.
- To evaluate the efficacy of this coating in preventing biofilm formation and treating VAP in an animal model.
Main Methods:
- A hydrogel coating (FK-MEM@CMCO-CS) was fabricated on PVC-based ETTs using chitosan, sodium carboxymethyl cellulose oxidation (CMCO), meropenem (MEM), and FK13-a1.
- The coating incorporated bromothymol blue (BTB) for pH-based visual indication of bacterial activity.
- In vitro and in vivo (VAP rat model) studies were conducted to assess coating performance.
Main Results:
- The FK-MEM@CMCO-CS coating exhibited pH-responsive release of MEM and FK13-a1.
- Significant inhibition of bacterial biofilm formation and adhesion was observed.
- In vivo, the coating reduced bacterial growth, lung inflammation, and demonstrated good biocompatibility.
Conclusions:
- The developed FK-MEM@CMCO-CS coating is an effective antimicrobial solution for ETTs, capable of signaling infection and delivering drugs.
- This technology shows promise for preventing VAP and has potential for industrial-scale production.
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Hand hygiene
Hand washing...

